Page last updated: 2024-10-24

chetomin and Prostatic Neoplasms, Castration-Resistant

chetomin has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

chetomin: C31H30N6O6S4, similar to epipolythiodioxopiperazines
chetomin : An organic heteropentacyclic compound of the class of epipolythiodioxopiperazine. Isolated from Chaetomium globosum and Farrowia seminuda, it exhibits immunosuppressive activity.

Prostatic Neoplasms, Castration-Resistant: Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fernandez, EV1
Reece, KM1
Ley, AM1
Troutman, SM1
Sissung, TM1
Price, DK1
Chau, CH1
Figg, WD1

Other Studies

1 other study available for chetomin and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells.
    Molecular pharmacology, 2015, Volume: 87, Issue:6

    Topics: Antineoplastic Agents; Benzamides; Cell Hypoxia; Cell Line, Tumor; Cobalt; Dihydrotestosterone; Disu

2015